INOVIQ Ltd (ASX:IIQ)
0.2050
+0.0100 (5.13%)
Aug 7, 2026, 4:10 PM AEST
INOVIQ Market Cap
INOVIQ has a market cap or net worth of 28.86 million as of August 7, 2026. Its market cap has decreased by -33.71% in one year.
Market Cap
28.86M
Enterprise Value
15.33M
Revenue
2.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
ChartMarket Cap Chart
Since June 20, 2016, INOVIQ's market cap has increased from 13.25M to 28.86M, an increase of 117.84%. That is a compound annual growth rate of 7.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 28.86M | -47.10% |
| Dec 31, 2025 | 54.55M | -5.02% |
| Dec 31, 2024 | 57.44M | -6.14% |
| Dec 29, 2023 | 61.19M | 3.91% |
| Dec 30, 2022 | 58.89M | -46.44% |
| Dec 31, 2021 | 109.96M | 102.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 441.54M |
| Healius | 297.72M |
| Monash IVF Group | 272.74M |
| Cryosite | 58.57M |
| Microba Life Sciences | 33.70M |
| Rhythm Biosciences | 30.43M |
| BCAL Diagnostics | 23.96M |
| ImExHS | 16.49M |